Pentixapharm Holding AG (ETR:PTP) | WebDisclosure

Basculer en Français

9815	Companies
196874	Keywords
127933	Articles
104696	Press releases

Headlines Articles Press releases Pentixapharm Holding AG

Home
Companies
Pentixapharm Holding AG

PRESS RELEASE

published on 01/24/2025 at 17:00, 1 year ago

EQS-Adhoc: Pentixapharm Holding AG Closes the 2024 Financial Year With a Loss of EUR 14 Million, Including Risk Provisions for Myelo Amounting to EUR 7 Million
Pentixapharm Holding AG reports a 2024 financial year loss of EUR 14 million, including risk provisions for Myelo. Find more details in the upcoming annual report

Annual Report Risk Provisions Pentixapharm Holding AG Financial Year Loss Myelo
BRIEF

published on 01/07/2025 at 10:35, 1 year ago

Pentixapharm obtient 6,77 millions d'euros auprès des actifs de Glycotope

Transaction Pentixapharm Glycotope Acquisition Pharmaceutique Actifs Incorporels
BRIEF

published on 01/07/2025 at 10:35, 1 year ago

Pentixapharm Secures EUR 6.77 Million from Glycotope Assets

Transaction Pentixapharm Glycotope Pharmaceutical Acquisition Intangible Assets
PRESS RELEASE

published on 01/07/2025 at 10:30, 1 year ago

Pentixapharm Receives EUR 6.77 Million for Intangible Assets Formerly Developed by Glycotope
Pentixapharm receives EUR 6.77 million for intangible assets formerly developed by Glycotope from undisclosed Asian pharma and biotech companies, eliminating remaining earn-out obligations

Acquisition Pharma Pentixapharm Glycotope Intangible Assets
PRESS RELEASE

published on 11/21/2024 at 13:41, 1 year 2 months ago

Original-Research: Pentixapharm Holding AG (von BankM AG): Kaufen
Pentixapharm Holding AG gibt den Start der klinischen Studie PENTILULA bekannt, um AML und ALL zu behandeln. Analysten bestätigen Kaufempfehlung und Kursziel. Neue Therapie mit Lutetium-177

Pentixapharm Holding AG Lutetium-177 PENTILULA AML ALL
BRIEF

published on 11/21/2024 at 11:05, 1 year 2 months ago

Pentixapharm Advancing Clinical Trials for Leukemia Treatment

Clinical Trial Radiopharmaceuticals Pentixapharm Lu-177 Leukemia Treatment
BRIEF

published on 11/21/2024 at 11:05, 1 year 2 months ago

Pentixapharm fait progresser les essais cliniques pour le traitement de la leucémie

Essai Clinique Produits Radiopharmaceutiques Pentixapharm Lu-177 Traitement De La Leucémie
PRESS RELEASE

published on 11/21/2024 at 11:00, 1 year 2 months ago

First Patient Treated in Phase I/II Trial in Acute Myeloid and Acute Lymphoblastic Leukemia with Lu177-PentixaTher, Expanding the Evidence Base for Targeted Radiotherapy Approach
Pentixapharm starts Phase I/II trial treating leukemia with Lu177-PentixaTher, a targeted radiotherapy. Study aims to expand treatment options for hematologic malignancies

Phase I/II Trial Leukemia Pentixapharm Radiotherapy Lu177-PentixaTher
BRIEF

published on 11/12/2024 at 17:50, 1 year 2 months ago

Pentixapharm publie ses résultats intermédiaires du troisième trimestre 2024

Perte Financière Spin Off Rapport Intérimaire Pentixapharm Troisième Trimestre
BRIEF

published on 11/12/2024 at 17:50, 1 year 2 months ago

Pentixapharm Reports Third Quarter 2024 Interim Results

Interim Report Spin-off Financial Loss Third Quarter Pentixapharm

Accesswire

Published on 02/05/2026 at 17:35, 1 hour 9 minutes ago

Pentagon I Capital Corp. Enters into Letter Agreement to Complete Qualifying Transaction with Prospectiva Resources Ltd.
Published on 02/05/2026 at 16:40, 2 hours 4 minutes ago

Relevant Gold Appoints Larry Taddei to Board of Directors and Mal Karwowska as Strategic Advisor
Published on 02/05/2026 at 15:45, 2 hours 59 minutes ago

American Critical Minerals Recaps a Highly Successful 6 Months and Files Amended and Restated Technical Report
Published on 02/05/2026 at 15:10, 3 hours 34 minutes ago

Electric Metals (USA) Limited Announces Change of Auditor
Published on 02/05/2026 at 14:50, 3 hours 54 minutes ago

High Tide Resources Announces Non-Brokered Private Placements

View all ACCESSWIRE

EQS Group

Published on 02/05/2026 at 18:09, 35 minutes ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/05/2026 at 17:55, 49 minutes ago

Piramal Critical Care and Blue-Zone Technologies collaborate to capture, collect and recycle waste anaesthesia gas
Published on 02/05/2026 at 17:40, 1 hour 4 minutes ago

BROADPEAK SA: Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social au 01.02.26.
Published on 02/05/2026 at 17:40, 1 hour 4 minutes ago

UV GERMI : MISE À DISPOSITION DE LA NOTE D’INFORMATION ET DU DOCUMENT « AUTRES INFORMATIONS » DANS LE CADRE DE L’OFFRE PUBLIQUE DE RACHAT D’ACTIONS INITIÉE PAR UV GERMI
Published on 02/05/2026 at 17:05, 1 hour 39 minutes ago

European Research and Innovation: the Politecnico di Milano Launches an Office in Brussels

Les Echos

Published on 02/05/2026 at 18:24, 20 minutes ago

LNA SANTE : 2025 annual sales
Published on 02/05/2026 at 18:12, 32 minutes ago

LNA SANTE : Chiffre d'affaires annuel 2025
Published on 02/05/2026 at 18:06, 37 minutes ago

Aéroports de Paris SA - Actions et droits de vote au 31 janvier 2026
Published on 02/05/2026 at 18:06, 37 minutes ago

Aéroports de Paris SA - Shares and voting rights as of 31 January 2026
Published on 02/05/2026 at 18:00, 44 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of January 30, 2026

View all LES ECHOS COMFI WIRE